These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30366349)

  • 1. Osteocytes.
    Rupp M; Merboth F; Daghma DE; Biehl C; El Khassawna T; Heiß C
    Z Orthop Unfall; 2019 Apr; 157(2):154-163. PubMed ID: 30366349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
    Sapir-Koren R; Livshits G
    Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.
    Pathak JL; Bravenboer N; Klein-Nulend J
    Front Endocrinol (Lausanne); 2020; 11():405. PubMed ID: 32733380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteocytes and Wnt signaling.].
    Fukumoto S
    Clin Calcium; 2019; 29(3):317-321. PubMed ID: 30814376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy.
    Toscani D; Bolzoni M; Ferretti M; Palumbo C; Giuliani N
    Front Immunol; 2018; 9():2467. PubMed ID: 30410490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone and Nutrition. Sclerostin and bone metabolism].
    Tatsumi S; Nagamoto K; Ogata M; Miyamoto K
    Clin Calcium; 2015 Jul; 25(7):1043-7. PubMed ID: 26119318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
    Wang T; Yu X; He C
    Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of osteocyte function and the emerging importance of sclerostin.
    Compton JT; Lee FY
    J Bone Joint Surg Am; 2014 Oct; 96(19):1659-68. PubMed ID: 25274791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Osteocyte: New Insights.
    Robling AG; Bonewald LF
    Annu Rev Physiol; 2020 Feb; 82():485-506. PubMed ID: 32040934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How much do we know about the role of osteocytes in different phases of fracture healing? A systematic review.
    Choy MHV; Wong RMY; Chow SKH; Li MC; Chim YN; Li TK; Ho WT; Cheng JCY; Cheung WH
    J Orthop Translat; 2020 Mar; 21():111-121. PubMed ID: 32309136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
    Niedźwiedzki T; Filipowska J
    J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
    Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
    Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bromodomain Inhibitor
    Siegenthaler B; Ghayor C; Gjoksi-Cosandey B; Ruangsawasdi N; Weber FE
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin: recent advances and clinical implications.
    Honasoge M; Rao AD; Rao SD
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):437-46. PubMed ID: 25333305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology of bone metabolism].
    Jakob F; Seefried L; Ebert R
    Internist (Berl); 2008 Oct; 49(10):1159-60, 1162, 1164 passim. PubMed ID: 18810375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin.
    Knowles HJ; Chanalaris A; Koutsikouni A; Cribbs AP; Grover LM; Hulley PA
    Front Endocrinol (Lausanne); 2023; 14():1167734. PubMed ID: 37223031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.
    Brabnikova Maresova K; Pavelka K; Stepan JJ
    Calcif Tissue Int; 2013 Apr; 92(4):354-61. PubMed ID: 23247536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck.
    Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J
    Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts.
    Han Y; You X; Xing W; Zhang Z; Zou W
    Bone Res; 2018; 6():16. PubMed ID: 29844945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.